Skip to main content
Livermore
Livermore
ZHEN

HM Payson & Co

SEC CIK
0000928052
Latest filing
Jul 17, 2026

AZN holding history

AstraZeneca PLC in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AZN overviewAll 13F holders of AZNFull Q2 2026 holdings

Shares (Q2 2026)
20,928
Value
$3.97M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of AZN by HM Payson & Co, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202620,928$3.97M0.1%−3,063−12.8%ReducedHolders
Q1 202623,991$4.73M0.1%−1,768−6.9%ReducedConverted for a 1-for-2 splitHolders
Q4 202551,517$4.74M0.1%+18,945+58.2%AddedHolders
Q3 202532,572$2.50M<0.1%−2,458−7.0%ReducedHolders
Q2 202535,030$2.45M<0.1%−20,303−36.7%ReducedHolders
Q1 202555,333$4.07M0.1%+49,772+895.0%AddedHolders
Q4 20245,561$364.4K<0.1%−59,953−91.5%ReducedHolders
Q3 202465,514$5.10M0.1%+61,805+1,666.4%AddedHolders
Q2 20243,709$289.3K<0.1%+14+0.4%AddedHolders
Q1 20243,695$250.3K<0.1%+5+0.1%AddedHolders
Q4 20233,690$248.5K<0.1%−937−20.3%ReducedHolders
Q3 20234,627$313.3K<0.1%+2,268+96.1%AddedHolders
Q2 20232,359$168.8K<0.1%+280+13.5%AddedHolders
Q1 20232,079$144.3K<0.1%−23−1.1%ReducedHolders
Q4 20222,102$142.5K<0.1%+79+3.9%AddedHolders
Q3 20222,023$111.0K<0.1%00.0%UnchangedHolders
Q2 20222,023$134.0K<0.1%−230−10.2%ReducedHolders
Q1 20222,253$149.0K<0.1%+2,000+790.5%AddedHolders
Q4 2021253$15.0K<0.1%00.0%UnchangedHolders
Q3 2021253$15.0K<0.1%00.0%UnchangedHolders
Q2 2021253$15.0K<0.1%−527−67.6%ReducedHolders
Q1 2021780$39.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.